−DNA variation: does not lead to cancer; it modifies molecular traits that go on to affect breast cancer risk−High levels of AA and low levels of ω-3 LC-PUFAs−Individuals who exhibit lower FADS1 activity (T allele) benefit from ω-3 LC-PUFAs by reduction in risk of breast cancer. This evidence concerns the gene FADS1 and cancer.